April 3, 2019
Sandoz resubmitting BLA for chemotherapy drug to the FDA
Sandoz is resubmitting its Biologics License Application for a proposed biosimilar pegfilgrastim to the US FDA
Pharmaceuticals, Biotechnology and Life Sciences
Tag: neutropenia